University of Cincinnati Study Raises Questions Associated with Use of Remdesivir in COVID-19 Patients

University of Cincinnati Study Raises Questions Associated with Use of Remdesivir in COVID-19 Patients

Much attention was placed on the antiviral drug remdesivir during the early stages of the COVID-19 pandemic. In fact, considerable public money was allocated to support ongoing studies, such as those sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH); the ACTT-1 study led to the emergency use authorization of the drug for COVID-19 patients. During that study, the NIAID sponsor changed the endpoint toward the end of the study, an unusual move that ensured sufficient results for a positive decision. The outcome of that study led to the declaration by Dr. Anthony Fauci, NIAID’s director, that remdesivir was a new standard of care; the U.S. Food and Drug Administration (FDA) issued an emergency use authorization in May as the pandemic raged and something needed to be done. The FDA finally approved the drug in October—the only such antiviral approved antiviral for COVID-19 in America—and as a consequence, TrialSite reported sales exploded with the drug’s maker, Gilead, generating at least $1 billion but perhaps over $1.5 billion in the first several months of the pandemic. But how safe and effective was this d...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee